Little Green Pharma Ltd (ASX:LGP)
Australia · Delayed Price · Currency is AUD 0.1200
-0.0050 (-4.00%)
Dec 5, 2025, 4:10 PM AEST
Little Green Pharma Income Statement
Financials in millions AUD. Fiscal year is April - March.
Millions AUD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Jun '21 Jun 30, 2021 | 2017 - 2020 |
Operating Revenue | 38.49 | 36.82 | 25.63 | 19.86 | 14.04 | 7 | Upgrade |
Other Revenue | - | 0.02 | 1.49 | - | - | - | Upgrade |
| 38.49 | 36.84 | 27.12 | 19.86 | 14.04 | 7 | Upgrade | |
Revenue Growth (YoY) | 26.76% | 35.85% | 36.55% | 41.45% | 100.47% | 217.77% | Upgrade |
Cost of Revenue | 10.92 | 11.9 | 6.22 | 6.06 | 6.69 | 1.23 | Upgrade |
Gross Profit | 27.57 | 24.94 | 20.9 | 13.8 | 7.35 | 5.78 | Upgrade |
Selling, General & Admin | 21.89 | 22.04 | 22.37 | 19.52 | 25.66 | 8.21 | Upgrade |
Research & Development | 0.08 | 0.29 | 0.58 | 1.47 | 4.06 | -1.6 | Upgrade |
Other Operating Expenses | 0 | 0.01 | 0.07 | - | - | - | Upgrade |
Operating Expenses | 28.05 | 28.47 | 28.35 | 20.98 | 29.72 | 6.61 | Upgrade |
Operating Income | -0.47 | -3.53 | -7.45 | -7.18 | -22.37 | -0.83 | Upgrade |
Interest Expense | -0.32 | -0.29 | -0.58 | -0.93 | -0.72 | -0.09 | Upgrade |
Interest & Investment Income | 0.04 | 0.02 | 0.17 | 0.05 | 0.04 | 0.04 | Upgrade |
Currency Exchange Gain (Loss) | -0.07 | -0.05 | 0.01 | -0.56 | -1.35 | -0.01 | Upgrade |
Other Non Operating Income (Expenses) | -0.09 | -0.09 | -0.06 | 0.06 | 0.33 | 0.52 | Upgrade |
EBT Excluding Unusual Items | -0.91 | -3.95 | -7.91 | -8.56 | -24.07 | -0.38 | Upgrade |
Asset Writedown | -1.35 | -0.85 | -0.24 | - | - | - | Upgrade |
Other Unusual Items | - | - | - | - | - | 22.59 | Upgrade |
Pretax Income | -2.26 | -4.79 | -8.15 | -8.56 | -24.07 | 22.22 | Upgrade |
Income Tax Expense | -8.12 | -8.12 | - | - | - | - | Upgrade |
Earnings From Continuing Operations | 5.86 | 3.32 | -8.15 | -8.56 | -24.07 | 22.22 | Upgrade |
Earnings From Discontinued Operations | - | - | - | -0.65 | -0.31 | - | Upgrade |
Net Income | 5.86 | 3.32 | -8.15 | -9.21 | -24.38 | 22.22 | Upgrade |
Net Income to Common | 5.86 | 3.32 | -8.15 | -9.21 | -24.38 | 22.22 | Upgrade |
Shares Outstanding (Basic) | 304 | 302 | 300 | 250 | 236 | 154 | Upgrade |
Shares Outstanding (Diluted) | 304 | 302 | 300 | 250 | 236 | 166 | Upgrade |
Shares Change (YoY) | 0.95% | 0.93% | 19.91% | 5.90% | 42.33% | 29.56% | Upgrade |
EPS (Basic) | 0.02 | 0.01 | -0.03 | -0.04 | -0.10 | 0.14 | Upgrade |
EPS (Diluted) | 0.02 | 0.01 | -0.03 | -0.04 | -0.10 | 0.13 | Upgrade |
Free Cash Flow | -1.91 | -1.15 | -0.65 | -8.76 | -33.07 | -6.05 | Upgrade |
Free Cash Flow Per Share | -0.01 | -0.00 | -0.00 | -0.04 | -0.14 | -0.04 | Upgrade |
Gross Margin | 71.63% | 67.70% | 77.07% | 69.50% | 52.38% | 82.47% | Upgrade |
Operating Margin | -1.23% | -9.59% | -27.48% | -36.17% | -159.33% | -11.90% | Upgrade |
Profit Margin | 15.21% | 9.02% | -30.06% | -46.35% | -173.66% | 317.20% | Upgrade |
Free Cash Flow Margin | -4.95% | -3.13% | -2.39% | -44.10% | -235.51% | -86.36% | Upgrade |
EBITDA | 2.64 | -0.28 | -4.57 | -4.35 | -21.06 | -0.35 | Upgrade |
EBITDA Margin | 6.86% | -0.76% | -16.87% | -21.90% | -150.01% | -5.01% | Upgrade |
D&A For EBITDA | 3.11 | 3.25 | 2.88 | 2.83 | 1.31 | 0.48 | Upgrade |
EBIT | -0.47 | -3.53 | -7.45 | -7.18 | -22.37 | -0.83 | Upgrade |
EBIT Margin | -1.23% | -9.59% | -27.48% | -36.17% | -159.33% | -11.90% | Upgrade |
Revenue as Reported | - | - | - | - | 14.04 | - | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.